Role of Bioinformatics in cancer research and drug development
Authors:
- Anam BegABAnam Beg
- Rafat ParveenRPRafat Parveen
- 1 January 2021
- book chapter
- Published by Elsevier
- p. 141-148
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- High throughput screening, docking, and molecular dynamics studies to identify potential inhibitors of human calcium/calmodulin-dependent protein kinase IVJournal of Biomolecular Structure and Dynamics, 2018
- Bioinformatics for cancer immunology and immunotherapyCancer Immunology, Immunotherapy, 2012
- BRCA1/2 mutations and expression: Response to platinum chemotherapy in patients with advanced stage epithelial ovarian cancerGynecologic Oncology, 2012
- EverolimusPediatric Drugs, 2012
- TREAT: a bioinformatics tool for variant annotations and visualizations in targeted and exome sequencing dataBioinformatics, 2011
- PROVENGE (Sipuleucel-T) in Prostate Cancer: The First FDA-Approved Therapeutic Cancer VaccineClinical Cancer Research, 2011
- Nanomedicine in cancer therapy: Innovative trends and prospectsCancer Science, 2011
- Sunitinib (Sutent®): A novel agent for the treatment of metastatic renal cell carcinomaJournal of Oncology Pharmacy Practice, 2007
- Prostate-cancer screening targets men with BRCA mutationsThe Lancet Oncology, 2002
- BRCAPRO Validation, Sensitivity of Genetic Testing of BRCA1/BRCA2, and Prevalence of Other Breast Cancer Susceptibility GenesJournal of Clinical Oncology, 2002